Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug Resistant Epilepsy and New AEDs: Two Perspectives.

Literature DB >> 30464729

Drug Resistant Epilepsy and New AEDs: Two Perspectives.

Abstract

Entities: Disease

Year: 2018 PMID： 30464729 PMCID： PMC6224145 DOI： 10.5698/1535-7597.18.5.304

Source DB: PubMed Journal: Epilepsy Curr ISSN： 1535-7511 Impact factor: 7.500

Keyword Cloud
References

× No keyword cloud information.

13 in total

Review 1. Drug-resistant epilepsy.

Authors: Patrick Kwan; Steven C Schachter; Martin J Brodie
Journal: N Engl J Med Date: 2011-09-08 Impact factor: 91.245

2. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study.

Authors: Zhibin Chen; Martin J Brodie; Danny Liew; Patrick Kwan
Journal: JAMA Neurol Date: 2018-03-01 Impact factor: 18.302

Review 3. Outcomes in newly diagnosed epilepsy in adolescents and adults: Insights across a generation in Scotland.

Authors: Martin J Brodie
Journal: Seizure Date: 2016-09-03 Impact factor: 3.184

4. Diagnosing refractory epilepsy: response to sequential treatment schedules.

Authors: R Mohanraj; M J Brodie
Journal: Eur J Neurol Date: 2006-03 Impact factor: 6.089

5. Drug treatment of epilepsy in the century of the ILAE: the first 50 years, 1909-1958.

Authors: Simon D Shorvon
Journal: Epilepsia Date: 2009-03 Impact factor: 5.864

Review 6. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.

Authors: Tracy Glauser; Elinor Ben-Menachem; Blaise Bourgeois; Avital Cnaan; Carlos Guerreiro; Reetta Kälviäinen; Richard Mattson; Jacqueline A French; Emilio Perucca; Torbjorn Tomson
Journal: Epilepsia Date: 2013-01-25 Impact factor: 5.864

7. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States.

Authors: Shih-Yin Chen; Ning Wu; Luke Boulanger; Patricia Sacco
Journal: J Med Econ Date: 2012-11-28 Impact factor: 2.448

8. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors: Andres M Kanner; Eric Ashman; David Gloss; Cynthia Harden; Blaise Bourgeois; Jocelyn F Bautista; Bassel Abou-Khalil; Evren Burakgazi-Dalkilic; Esmeralda Llanas Park; John Stern; Deborah Hirtz; Mark Nespeca; Barry Gidal; Edward Faught; Jacqueline French
Journal: Neurology Date: 2018-06-13 Impact factor: 9.910

9. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

Authors: Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal: Lancet Date: 2007-03-24 Impact factor: 79.321

10. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.